MNEXSPIKE Trademark

Trademark Overview

On Thursday, January 4, 2024, a trademark application was filed for MNEXSPIKE with the United States Patent and Trademark Office. The USPTO has given the MNEXSPIKE trademark a serial number of 98341867. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, June 9, 2025. This trademark is owned by ModernaTX, Inc.. The MNEXSPIKE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
mnexspike

General Information

Serial Number98341867
Word MarkMNEXSPIKE
Filing DateThursday, January 4, 2024
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, June 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameModernaTX, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameModernaTX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Sunday, March 31, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, March 31, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, March 31, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 31, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 4, 2024NEW APPLICATION ENTERED
Friday, February 16, 2024TEAS PETITION TO DIRECTOR RECEIVED
Sunday, March 31, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 5, 2024PETITION TO DIRECTOR GRANTED
Wednesday, April 3, 2024ASSIGNED TO PETITION STAFF
Monday, April 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2024ASSIGNED TO EXAMINER
Monday, April 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 10, 2024SOU EXTENSION 1 GRANTED
Tuesday, December 10, 2024SOU EXTENSION 1 FILED
Tuesday, December 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 9, 2025SOU TEAS EXTENSION RECEIVED
Monday, June 9, 2025SOU EXTENSION 2 FILED
Monday, June 9, 2025SOU EXTENSION 2 GRANTED
Monday, September 8, 2025TEAS STATEMENT OF USE RECEIVED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

mnexspike human vaccines